Over 15,000 surviving organ transplants recipients live in Australia with numbers rising as transplant rates increase. Skin cancer is a considerable problem for white-skinned organ transplant recipients: the incidence is at least 80 times higher on average than the already high background Australian rate. Transplant recipients are also more likely to experience aggressive, rapidly metastatic disease. The Skin Tumours in Allograft Recipients (STAR) Study aims to document the epidemiology of skin cancers and related skin tumours in organ transplant patients who are at especially high-risk due to previous skin tumours or a long period on immunosuppressant therapy. We are also assessing the costs imposed by skin cancer on individual patients and the health system.